Integra Therapeutics’ €4.5 Million Financing Round

Cuatrecasas advised Invivo Capital, Advent Biotechnology and Takeda Ventures on the round of financing in Integra Therapeutics.At closure of the transaction, the spin-off of Universitat Pompeu…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here